Testing effectiveness (Phase 2)UnknownNCT03830411
What this trial is testing
Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy
Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 76